8-10 April 2015
The 6th Annual conference brings researchers and clinicians together to discuss molecular targets
Molecular Targets for Predictive and Personalized Medicine of Cancer
Dr Yokota of the IMPPC and Dr Rafael Rosell of the Catalan Institute of Oncology declared the 6th Annual IMPPC Conference, Molecular Targets for Predictive and Personalized Medicine of Cancer to be a great success.
The conference included prestigious speakers ranging from basic researchers to clinical practitioners working in the field of personalized cancer medicine. The lively sessions were well attended and delegates agreed that it was a great opportunity for scientists and clinicians to share their ideas on the problems to be solved in the future.
Dr Takashi Kohno of the National Cancer Center Research Institute (NCCRI) in Japan and Dr Rosell comprehensively reviewed the recent advances and future directions of research into target therapies for cancer. In particular, target therapies have been successfully applied in lung adenocarcinoma and over the last decade the prognosis for this disease has been significantly improved by integrating this type of treatment with more standard therapies.
Another important topic was the discussion of two important target oncogenes: MYC and KRAS, because of the high relevance of their activation in human cancer and the difficulty in controlling their activities. Dr Barbacid of the Spanish National Cancer Research Center, Madrid (CNIO) and Dr Balmain of the University of California, San Francisco (USCSF) demonstrated several targetable molecules in KRAS mutated cancer cells. Dr Soucek of the Vall d'Hebron Institute of Oncology (VHIO) and Dr Yokota showed the utility of dominant negative MYC for suppressing the growth of cancer cells. Through the use of genome-wide analyses, novel molecular targets for diagnosis and treatment have also been identified in recent years. Dr Croce of the University of Ohio and Dr Harris of the National Cancer Institute (NCI) emphasized the importance of non-coding RNA for the understanding of molecular pathways driving human cancer.
In addition to the 20 invited speakers, 30 young poster-presenters had the opportunity to summarize the main point of their work in the lively fast-track presentations and 4 young scientists selected from abstract submissions gave short-talks. The speakers, poster presenters and delegates had a plenty of time for interaction and discussion other during coffee and lunch breaks. On Thursday evening the Migjorn Quartet entertained the scientists with a selection from their repertoire of chamber music.
Dr Perucho, Director of the IMPPC, expressed his satisfaction with the six IMPPC Annual Conferences held since 2010 and announced a new series to start in 2016.